KRMD

KORU Medical Systems, Inc.

Nasdaq· Surgical & Medical Instruments & Apparatus· Inc. DE· CIK 0000704440 Healthcare & Medical Devices

$3.12 −0.05 (−1.58%)

Oct 26 4:00 PM ET · prev $3.17

Market cap

$142.0M

Micro cap

Median target

$6.00

+92% · range $5.00–8.00

Next earnings

Nov 10

in 14 days · EPS est. −$0.02

1 year

−24.5%

from $4.13 · Oct 27

30 days

+2.0%

from $3.06

52-week range

$2.93–6.52

−52% from high · low Sep 30

Avg volume 20D

197.1K

shares / day

Short interest

🔒 Subscribers only

Insider net

+$215.3K

5 buyers · 0 sellers · since Feb 13

New fund stakes

Q2 2026 13F · 0 exits

Filing reports

analyzed by SecBot

SecBot read MIXED 2 reports · latest

Balance 0 bearish · 0 bullish · 2 neutral oldest → newest, height = score

Avg score

·Next Earnings date, Nov 10, 2026

Strongest NEUTRAL A mixed institutional cluster for KRMD in Q1 2026 shows 4 buyers adding $704K (led by Russell Investments'…

All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

B May 14 to May 18 3 days of insider buys: $64.9K by 4 insiders, avg $3.89
R May 20 KORU Medical Systems insiders executed a concentrated buying cluster…
R May 20 Three senior insiders at KORU Medical Systems — CEO, CFO, and COO —…
R May 20 CEO Linda Tharby made a $1.42M open-market purchase, the largest ins…
B Jun 11 1 insider buy $49.3K at $3.94
B Sep 8 1 insider buy $101.1K at $3.16

Signal stack

Where each data set points today.

InsidersBULLISH

5 insiders bought $215.3K at an average $3.52. No open-market sales. Price is 11% below their cost.
InstitutionsMIXED

Q2 2026: 7 added (0 new), 5 trimmed or exited.
EstimatesFALLING

Current-quarter EPS estimate $0.005 → −$0.020 over 90 days. 0 up, 1 down in 30 days.
TrendDOWNTREND

1% below its 50-day average.

Who's buying

13F· Q2 2026

new positions

exits

Fund	Move	Shares	Value
Russell Investments Group, Ltd.	TRIM	269,586	$1.1M
RENAISSANCE TECHNOLOGIES LLC	DOUBLED	164,900	$692.6K
Squarepoint Ops LLC	DOUBLED	124,755	$524.0K
GOLDMAN SACHS GROUP INC	TRIM	100,475	$422.0K
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	DOUBLED	52,872	$222.1K
WELLS FARGO & COMPANY/MN	DOUBLED	41,131	$172.8K
PRICE T ROWE ASSOCIATES INC /MD/	ADD	36,991	$156.0K
CITADEL ADVISORS LLC	TRIM	28,520	$119.8K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Mar 2026

12-month targets · 4 analysts

$3.12 $5.00 $6.00 $8.00

Price is below the lowest target. Median implies +92%.Targets as of Oct 27, 2026.

Recent actions

Date	Firm	Action	Rating
Mar 13, 2026	Canaccord Genuity MAINTAIN	MAINTAIN	Buy
Mar 13, 2026	B. Riley Securities MAINTAIN	MAINTAIN	Buy
Dec 22, 2025	Lake Street MAINTAIN	MAINTAIN	Buy
Dec 17, 2025	Canaccord Genuity MAINTAIN	MAINTAIN	Buy
Aug 7, 2025	Piper Sandler MAINTAIN	MAINTAIN	Neutral
May 8, 2025	Piper Sandler MAINTAIN	MAINTAIN	Neutral

Insider ledger

Form 4

$215.3K

bought · 5 insiders

sold · 0 insiders

−11.3%

vs their $3.52 cost

Date	Insider	Type	Value
Oct 1, 2026	FLETCHER R JOHN Director	AWARD	$22.5K
Oct 1, 2026	WHOLIHAN EDWARD Director	AWARD	$15.0K
Oct 1, 2026	CASCELLA ROBERT Director	AWARD	$15.0K
Oct 1, 2026	French Donna Director	AWARD	$15.0K
Oct 1, 2026	Matin Shahriar Director	AWARD	$15.0K
Sep 30, 2026	Manko Joseph M. Jr. Director	AWARD	5,119 sh
Sep 8, 2026	KALBERMATTEN ADAM R Chief Commercial Officer	BUY	$101.1K
Jul 28, 2026	KALBERMATTEN ADAM R Chief Commercial Officer	EXERCISE	75,000 sh

Earnings setup

Estimates

Nov 10

reports in 14 days

−$0.02

EPS estimate, this quarter

−500%

estimate change, 90 days

0↑ 1↓

revisions, 30 days

Current-quarter EPS estimate

$0.005

90d

$0.005

60d

$0.005

30d

$0.005

−$0.020

Now

Period	EPS est.	Range	30D rev.	Revenue
Current Q	-$0.02	-$0.02–-$0.02	-500.0%	$11.3M
Next Q	$0.00	$0.00–$0.00	-100.0%	$12.9M
Current FY	-$0.01	-$0.01–$0.00	-125.0%	$48.0M
Next FY	🔒 Fresh data, subscribers only